Royalty Pharma plc Annual Costs and Expenses in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Royalty Pharma plc quarterly/annual Costs and Expenses history and growth rate from 2018 to 2024.
  • Royalty Pharma plc Costs and Expenses for the quarter ending June 30, 2025 was $369M, a 37.8% increase year-over-year.
  • Royalty Pharma plc Costs and Expenses for the twelve months ending June 30, 2025 was $465M, a 63.6% decline year-over-year.
  • Royalty Pharma plc annual Costs and Expenses for 2024 was $971M, a 12.6% increase from 2023.
  • Royalty Pharma plc annual Costs and Expenses for 2023 was $862M, a 55.3% decline from 2022.
  • Royalty Pharma plc annual Costs and Expenses for 2022 was $1.93B, a 125% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $971M +$109M +12.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-12
2023 $862M -$1.07B -55.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-12
2022 $1.93B +$1.07B +125% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-12
2021 $859M +$332M +63% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $527M +$1.34B Jan 1, 2020 Dec 31, 2020 10-K 2023-02-15
2019 -$809M -$1.24B -288% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $430M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.